Complex and Evolving Requirements
Conducting clinical research in Nigeria requires approval from national regulators as well as institutional ethics committees. For drug and vaccine trials, the National Agency for Food and Drug Administration and Control (NAFDAC) plays a central role. While this oversight is essential for participant safety and data integrity, researchers often encounter delays and uncertainties during the approval process. Understanding these challenges and planning ahead can make a significant difference.
Regulatory expectations can change as guidelines are updated to meet international standards. Sponsors and investigators sometimes submit applications that are incomplete or not fully aligned with current requirements, leading to queries and resubmissions. Differences between what is submitted to ethics committees and what is sent to NAFDAC can also create inconsistencies that slow approval.
Use the most recent official guidance documents and create a detailed submission checklist. Ensure that the protocol, investigator brochure, consent forms, and supporting documents are harmonised across all submissions before filing.
Lengthy Review Timelines
Regulatory review can take longer than expected, especially when applications generate multiple rounds of questions. High submission volumes and limited review capacity can contribute to delays, affecting study start dates and budgets.
How to manage it:
Build realistic timelines into project plans and submit as early as possible. Respond to regulatory queries quickly and clearly, providing complete answers rather than partial updates that may trigger further questions.
Documentation and Administrative Burden
Applications require extensive technical and administrative documentation, including product information, manufacturing details, insurance, contracts, and evidence of prior approvals. Missing or poorly prepared documents are a common reason for rejection or delay.
How to manage it:
Assign a dedicated regulatory lead or consultant to coordinate the submission. Use standard templates and conduct an internal quality check before submission to ensure all required attachments are complete and correctly formatted.
Coordination Between Multiple Approvals
In Nigeria, NAFDAC approval and ethics approval are both required, and the order and timing can be confusing for new sponsors. Lack of coordination can result in duplicated effort or stalled applications.
How to manage it:
Plan a parallel but well-coordinated submission strategy. Keep clear records of what has been submitted where, and promptly share approval letters or queries between the regulatory and ethics tracks when required.
Communication Gaps
Unclear or infrequent communication with regulators can leave applicants uncertain about application status. This may lead to unnecessary resubmissions or missed opportunities to clarify minor issues early.
How to manage it:
Maintain professional, respectful communication with the regulatory office. Where possible, seek pre-submission advice or clarification meetings to confirm expectations before filing.
Limited Local Regulatory Experience
Some research teams and sites are highly skilled clinically but less familiar with national regulatory processes. This learning curve can slow progress, particularly for first-time sponsors.
How to manage it:
Invest in regulatory training and partner with experienced local organisations that understand Nigerian requirements and review practices. Building local expertise reduces future delays.
Turning Challenges into a Structured Pathway
Although regulatory approval in Nigeria can be demanding, the system is designed to protect participants and ensure credible results. With early preparation, complete and consistent documentation, realistic timelines, and proactive communication, many of the common obstacles can be reduced or avoided.
A well-managed regulatory strategy does more than secure approval; it builds trust with authorities and creates a smoother pathway for future studies.
